Features
Ethical issues pertaining to subjects facing life-threatening disease
Life can change in an instant, but there is one thing that always abides; hope. Understanding the reality that comeswhen one is faced with a life threatening disease and understanding how hope, the unfailing feeling and expectation that tomorrow will be better, challenges autonomous decision-making explains why, still today, only 3% to 5% of cancer patients participate in clinical trials.
Linda Strause, PhD, Executive Director & Head, Clinical Operations, Vical Inc.; Research Scientist & Founder, Institute of Palliative Medicine & San Diego Hospice IRB
Circulating Tumor Cell Testing in Clinical Trials
Development of new anti-tumor drugs is time consuming and costly. If a drug does not effectively prolong patient survival time, it will not survive the fiercely competitivemarket. Is there an effective pharmacodynamic biomarker able to predict early success or failure of a drug candidate in development? Chengsen Xue, Carla G. Hill, and Thomas W. McCloskey, Research & Development Department, ICON Central Laboratories
The Art and Science of Imaging Analytics: An Image is Worth a Thousand Words...and Millions of Dollars
Rapid advances in image acquisition technology and continued developments in image analysis software are changing the depth and breadth of clinical research. Imaging permeates clinical and basic research across many scientific disciplines including oncology, orthopedics, ophthalmology, cardiology, and neurology, and across entities focusing on pharmaceuticals, medical device development, cell and molecular biology, tissue engineering and beyond.
Amit Vasanji, Ph.D, and Timothy J. Kulbago
| MARCH - SPECIAL INSERT |
|
eClinical
Using eClinical to achieve efficiencies, understanding and insights into your own clinical trial is a goal of many companies, however, the actuality may be less than optimum. Technology continues to challenge each aspect of the clinical trial chain, but there are ways to improve and enhance technology for sponsors and CROs. The articles in this insert are designed to inform and educate on the best practices for eClinical today. |
FOR INFORMATION ON ADVERTISING, CONTACT:
*June 2012 BPA Statement
**Publisher's Own Data
Editorial Subject to Change
